Ultrasound-Enhanced Chemiluminescence for Bioimaging

Tissue imaging has emerged as an important aspect of theragnosis. It is essential not only to evaluate the degree of the disease and thus provide appropriate treatments, but also to monitor the delivery of administered drugs and the subsequent recovery of target tissues. Several techniques including...

Full description

Bibliographic Details
Main Authors: Duong Le, Dinesh Dhamecha, Andrea Gonsalves, Jyothi U. Menon
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-02-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fbioe.2020.00025/full
id doaj-d971e42cd89f4e95bcd4c7064831e4bf
record_format Article
spelling doaj-d971e42cd89f4e95bcd4c7064831e4bf2020-11-25T02:51:45ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852020-02-01810.3389/fbioe.2020.00025496017Ultrasound-Enhanced Chemiluminescence for BioimagingDuong LeDinesh DhamechaAndrea GonsalvesJyothi U. MenonTissue imaging has emerged as an important aspect of theragnosis. It is essential not only to evaluate the degree of the disease and thus provide appropriate treatments, but also to monitor the delivery of administered drugs and the subsequent recovery of target tissues. Several techniques including magnetic resonance imaging (MRI), computational tomography (CT), acoustic tomography (AT), biofluorescence (BF) and chemiluminescence (CL), have been developed to reconstruct three-dimensional images of tissues. While imaging has been achieved with adequate spatial resolution for shallow depths, challenges still remain for imaging deep tissues. Energy loss is usually observed when using a magnetic field or traditional ultrasound (US), which leads to a need for more powerful energy input. This may subsequently result in tissue damage. CT requires exposure to radiation and a high dose of contrast agent to be administered for imaging. The BF technique, meanwhile, is affected by strong scattering of light and autofluorescence of tissues. The CL is a more selective and sensitive method as stable luminophores are produced from physiochemical reactions, e.g. with reactive oxygen species. Development of near infrared-emitting luminophores also bring potential for application of CL in deep tissues and whole animal studies. However, traditional CL imaging requires an enhancer to increase the intensity of low-level light emissions, while reducing the scattering of emitted light through turbid tissue environment. There has been interest in the use of focused ultrasound (FUS), which can allow acoustic waves to propagate within tissues and modulate chemiluminescence signals. While light scattering is decreased, the spatial resolution is increased with the assistance of US. In this review, chemiluminescence detection in deep tissues with assistance of FUS will be highlighted to discuss its potential in deep tissue imaging.https://www.frontiersin.org/article/10.3389/fbioe.2020.00025/fullchemiluminescencebioluminescencefocused ultrasounddeep tissueimaging
collection DOAJ
language English
format Article
sources DOAJ
author Duong Le
Dinesh Dhamecha
Andrea Gonsalves
Jyothi U. Menon
spellingShingle Duong Le
Dinesh Dhamecha
Andrea Gonsalves
Jyothi U. Menon
Ultrasound-Enhanced Chemiluminescence for Bioimaging
Frontiers in Bioengineering and Biotechnology
chemiluminescence
bioluminescence
focused ultrasound
deep tissue
imaging
author_facet Duong Le
Dinesh Dhamecha
Andrea Gonsalves
Jyothi U. Menon
author_sort Duong Le
title Ultrasound-Enhanced Chemiluminescence for Bioimaging
title_short Ultrasound-Enhanced Chemiluminescence for Bioimaging
title_full Ultrasound-Enhanced Chemiluminescence for Bioimaging
title_fullStr Ultrasound-Enhanced Chemiluminescence for Bioimaging
title_full_unstemmed Ultrasound-Enhanced Chemiluminescence for Bioimaging
title_sort ultrasound-enhanced chemiluminescence for bioimaging
publisher Frontiers Media S.A.
series Frontiers in Bioengineering and Biotechnology
issn 2296-4185
publishDate 2020-02-01
description Tissue imaging has emerged as an important aspect of theragnosis. It is essential not only to evaluate the degree of the disease and thus provide appropriate treatments, but also to monitor the delivery of administered drugs and the subsequent recovery of target tissues. Several techniques including magnetic resonance imaging (MRI), computational tomography (CT), acoustic tomography (AT), biofluorescence (BF) and chemiluminescence (CL), have been developed to reconstruct three-dimensional images of tissues. While imaging has been achieved with adequate spatial resolution for shallow depths, challenges still remain for imaging deep tissues. Energy loss is usually observed when using a magnetic field or traditional ultrasound (US), which leads to a need for more powerful energy input. This may subsequently result in tissue damage. CT requires exposure to radiation and a high dose of contrast agent to be administered for imaging. The BF technique, meanwhile, is affected by strong scattering of light and autofluorescence of tissues. The CL is a more selective and sensitive method as stable luminophores are produced from physiochemical reactions, e.g. with reactive oxygen species. Development of near infrared-emitting luminophores also bring potential for application of CL in deep tissues and whole animal studies. However, traditional CL imaging requires an enhancer to increase the intensity of low-level light emissions, while reducing the scattering of emitted light through turbid tissue environment. There has been interest in the use of focused ultrasound (FUS), which can allow acoustic waves to propagate within tissues and modulate chemiluminescence signals. While light scattering is decreased, the spatial resolution is increased with the assistance of US. In this review, chemiluminescence detection in deep tissues with assistance of FUS will be highlighted to discuss its potential in deep tissue imaging.
topic chemiluminescence
bioluminescence
focused ultrasound
deep tissue
imaging
url https://www.frontiersin.org/article/10.3389/fbioe.2020.00025/full
work_keys_str_mv AT duongle ultrasoundenhancedchemiluminescenceforbioimaging
AT dineshdhamecha ultrasoundenhancedchemiluminescenceforbioimaging
AT andreagonsalves ultrasoundenhancedchemiluminescenceforbioimaging
AT jyothiumenon ultrasoundenhancedchemiluminescenceforbioimaging
_version_ 1724733533032808448